Pfizer (PFE) Gets FDA Approval for Lyrica Caps in Neuropathic Pain Management Following Spinal Cord Injury
Go back to Pfizer (PFE) Gets FDA Approval for Lyrica Caps in Neuropathic Pain Management Following Spinal Cord Injury| Pfizer Inc. (NYSE: PFE) | Delayed: 27.25 +0.38 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.87 | 52 Week High | $37.39 | |||
| Open | $27.15 | 52 Week Low | $28.25 | |||
| Day High | $27.40 | P/E | 16.52 | |||
| Day Low | $27.10 | EPS | $1.65 | |||
| Volume | 34,627,655 | |||||
